SPECIMEN · REPORT 01 · ANONYMIZED

An anonymized sample report.
Read three pages here.
Email yourself the full 32.

Names, figures, and identifying details below are changed for confidentiality. Structure, depth, source standard, and recommendation style match what every client receives. View all three pages in this browser without giving an email — or get the full 32-page PDF in your inbox via the form below.

QUINTARA REPORTS · FR · 01 · Q1 2026CONFIDENTIAL · SAMPLE
EXECUTIVE SUMMARY · ONE PAGE

The answer, in 220 words.

Three direct competitors are closing on Acme’s pricing tier from below, while two are pulling away on distribution. The pressure on margin is real but solvable in 90 days without a price cut.

1 · NORDA (€4.1M ARR, Stockholm) just shipped a €19/mo subscription that undercuts your Plus tier by 32%. Their unit economics work because of a 4-product bundle. Two paths to neutralise: bundle pricing on your top-3 SKUs, or a loyalty hook tied to refill cadence.

2 · HALOWORK (€2.7M ARR, Lisbon) is winning on TikTok creator distribution at one-third of your CAC. They’re soft on retention (38% Y1 churn). A 60-day creator deal in your top-2 categories closes the gap.

3 · SOLVE (€8.9M ARR, Berlin) launches a derm-led B2B line in Q3. Their roadmap leaked via a German derm trade show — three SKUs, all retinol-derivative. You have a six-month head start on indication-led positioning (Chapter VI).

NAMED NEXT MOVEReprice the annual plan to €1,997 by Friday. Bundle the top 3 SKUs to neutralise NORDA’s entry tier. Implementing before Q2 push protects an estimated €420K of ARR. Full justification: pp. 14–17.

CONFIDENTIAL · SAMPLEPP. 03 / 32
QUINTARA REPORTS · FR · 01 · Q1 2026I · DIRECT COMPETITORS · NAMED & SCORED
I · DIRECT COMPETITORS · NAMED & SCORED

The five names, in order of threat.

RANKCOMPANYHQEST. ARRPRICE BANDTHREAT
1NordaStockholm, SE€4.1M€19–49/moHIGH
2Solve SkinBerlin, DE€8.9M€24–72/moHIGH
3HaloworkLisbon, PT€2.7M€16–32/moMEDIUM
4Verde & Co.Milan, IT€1.4M€22–55/moMEDIUM
5KlarCopenhagen, DK€0.9M€18–48/moLOW

ARR estimates derived from Companies House (UK), KvK (NL), Bolagsverket (SE) filings where available; cross-referenced with Similarweb traffic estimates and three primary interviews with ex-employees (one each at Norda and Solve, two at Halowork). Methodology in Chapter VII.

CONFIDENTIAL · SAMPLEPP. 04 / 32
QUINTARA REPORTS · FR · 01 · Q1 2026VII · SOURCES · EVERY CLAIM CITED
VII · SOURCES · EVERY CLAIM CITED, NONE PARAPHRASED

How we know what we know.

Every claim in this report carries a citation. There is no “industry wisdom” floor. If a number appears, you can trace it. If we couldn’t verify a claim, it isn’t in here.

  1. [1] Norda Holding AB · Annual filing 2025-Q4 · Bolagsverket reg. 559213-XXXX · accessed 2026-03-04
  2. [2] Solve GmbH · Press release 2026-02-14 · solveskin.com/press · derm-line announcement
  3. [3] Norda pricing page snapshot · 2026-03-08 14:22 CET · Wayback Machine archive
  4. [4] Primary interview · Ex-Growth at Norda (anonymised on request) · 2026-03-11 · 47 min
  5. [5] Primary interview · Ex-CMO at Halowork · 2026-03-12 · 38 min
  6. [6] Primary interview · Ex-Founder at Halowork (now advisor) · 2026-03-13 · 22 min
  7. [7] Similarweb traffic estimate (March 2026 monthly) · directional only · cross-referenced with citation [4]
  8. [8] Munich Beauty Trade Show floor notes · derm-line panel · 2026-02-19 · attended in person

Sources [4]–[6]: ex-employee interviews. Quintara’s standard is at least three primary sources for any threat-ranked competitor; two if confirming a non-strategic claim. Interview transcripts available to client on request, redacted for source-anonymity guarantees.

CONFIDENTIAL · SAMPLEPP. 31 / 32
OPTIONAL — EMAIL YOURSELF THE FULL 32 PAGES

You’ve already seen three pages above. The other 29 cover the pricing breakdown, positioning map, channel CAC analysis, product-gap teardown, and the “three moves they can’t copy” playbook. Drop your email if you’d like the full PDF for offline review — otherwise no email needed.

We use your email for the PDF and any optional field notes you check above. That’s it. No retargeting list-share. No third-party trackers behind this form. Privacy policy.

WHY THIS IS CREDIBLE

What separates a Quintara report from AI slop.

01

Every factual claim traceable.

No “industry wisdom.” If we cite a number, you can trace it to a filing, a transcript, or a screenshot in the appendix. AI cannot fabricate a source it has to provide.

02

At least three primary sources per ranked threat.

Public data is re-verified line by line; anything strategic is cross-checked with at least three primary interviews (founders, customers, ex-employees). Two for non-strategic claims.

03

Human-finalised, every page.

AI does the compilation pass. Damyan does the judgement pass — which claim survives, which evidence outweighs which, which next move to name. No report ships until each claim passes a source / relevance / decision-usefulness check.

04

If we can’t name a move, we say so.

When the evidence doesn’t support a clear recommendation, we say so on the cover and refund the brief. A hedged report isn’t worth shipping.